DNA-Encoded Library (DEL) Screening Services
Advanced DNA-encoded library (DEL) small molecule drug discovery screening services
BioDuro and X-Chem have partnered to provide DEL services since August 2022
High quality lead-like/drug-like focused libraries incorporating state-of-the-art DEL design and synthesis
Thorough protein QC and AI-powered comprehensive DEL selection data analysis
Hit structures with embedded SAR information provided to clients who are offered full freedom to operate
Transparent cost structure, no downstream financial obligations
Unmatched track record for DEL-driven hit identification by X-Chem, backed by comprehensive Discovery services (Chemistry, Biology, DMPK, Pharmacology) to rapidly advance clients’ discovery programs
DEL Screening Services Overview
BioDuro is an exclusive strategic partner of X-Chem in China. X-Chem is the leader in small molecule discovery science, providing pharmaceutical and biotech companies a complete, seamless solution for screening, hit validation and lead optimization. As pioneers of DNA-encoded chemical library (DEL) technology, X-Chem has been leading the DNA-encoded library (DEL) field for more than a decade, delivering over 90 programs to the partners and clients, comprising over 1,000 novel, validated hit compounds across more than 30 different target classes.
The BioDuro Advantage
X-Chem’s versatile DEL screening is proven in projects spanning numerous target classes. The robust process has been highly successful against targets considered difficult or even intractable
Protein-protein interactions
Ubiquitin ligases
Epigenetic targets
G protein-coupled receptors
Bacterial enzymes
Services
The platform, libraries and screening strategies are designed to generate compound classes that can address any target and modality
Lead-like compounds
Drug-like compounds
Macrocycles
Peptides
Covalent inhibitors
Protein degraders
Allosteric inhibitors